feeling shaky on semaglutide Ozempic (semaglutide) is a GLP-1 receptor agonist used for type 2 diabetes (and sometimes weight loss). Its side effects range from common GI symptoms to rare but serious risks. ⸻ 🟡 Common Is Semaglutide Your Ultimate Option

Some anti-inflammatory effects appear independent of weight loss, which is why microdosing is being explored for RA patients who aren't significantly overweight but have signs of metabolic inflammation

Pioglitazone and cardiovascular outcomes in patients with insulin resistance, prediabetes and type 2 diabetes: A systematic review and meta-analysis

It enhances feelings of fullness and reduces hunger, leading to significant weight loss, especially when combined with lifestyle changes

Craig CM, Liu L-F, Deacon CF, Holst JJ, McLaughlin TL

24 Instead, it appears to be highly modifiable

A subset of users report severe gastrointestinal issues and long-term health complications associated with its use